All news

After exercising options at

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Enliven Therapeutics (ELVN) director J. Scott Garland exercised options for 13,000 shares at

Read original source

ELVN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.